Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guangzhou Guocui Biotechnology is a Chinese biotechnology company specializing in the research, development, and production of bioactive substances and medical materials. The company focuses on the application of synthetic biology in medical aesthetics, dermatology, and health supplements, with a particular emphasis on recombinant humanized collagen and natural plant extracts. Guangzhou Guocui operates as a high-tech enterprise, integrating R&D with large-scale manufacturing to provide raw materials and finished medical devices for the healthcare industry. Their product portfolio includes innovative solutions for skin repair, anti-aging, and wound management, supported by advanced fermentation and purification technologies. By leveraging its synthetic biology platform, the company aims to replace traditional animal-derived materials with high-purity, bio-fermented alternatives.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guangzhou Guocui.